FDA inspection
Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc.: FDA inspection ending Mar 26, 2026
FDA inspection 1313468 · No Action Indicated (NAI) · Topeka, KS
Key facts
| Inspection ID | 1313468 |
|---|---|
| Firm | Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. |
| FEI number | 1971534 |
| Address | 6220 Sw 29th St Ste 100 |
| City | Topeka |
| State | KS |
| ZIP | 66614 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Mar 26, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data